Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.

Journal of medical economics

Volumn 14, Issue 1, 2011, Pages 75-86

  Lee, Lauren J ^a   Li, Qian ^b   Reynolds, Matthew W ^b   Pawaskar, Manjiri D ^b   Corrigan, Sheila M ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN;

ARTICLE; COMPARATIVE STUDY; DISPOSABLE EQUIPMENT; DRUG ADMINISTRATION ROUTE; ECONOMICS; FEMALE; HUMAN; HYPOGLYCEMIA; INSURANCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SYRINGE; UNITED STATES;

DIABETES MELLITUS, TYPE 2; DISPOSABLE EQUIPMENT; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SYRINGES; UNITED STATES;

EID: 84862833680     PISSN: None     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2010.546466     Document Type: Article

References (0)